Data as of 3:25pm ET
| +0.0016 / +0.13%|
The 3 analysts offering 12-month price forecasts for LifeVantage Corp have a median target of 2.10, with a high estimate of 3.00 and a low estimate of 1.69. The median estimate represents a +70.51% increase from the last price of 1.23.
The current consensus among 3 polled investment analysts is to Buy stock in LifeVantage Corp. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.